The establishment of a regression model from four modes of ultrasound to predict the activity of Crohn's disease
- PMID: 33420168
- PMCID: PMC7794219
- DOI: 10.1038/s41598-020-79944-1
The establishment of a regression model from four modes of ultrasound to predict the activity of Crohn's disease
Abstract
To establish a multi-parametric regression model from four modes of ultrasound to predict the activity of Crohn's disease (CD) noninvasively. Score of 150 of the Crohn's Disease Activity Index (CDAI) was taken as the cut-off value to divide the involved bowel segments of 51 patients into the active and inactive group. Eleven parameters from four modes of ultrasound (B-mode ultrasonography, color Doppler flow imaging, contrast-enhanced ultrasonography and shear wave elastography) were compared between the two groups to investigate the relationship between multimodal ultrasonic features and CD activity. P < 0.05 was considered statistically significant. Parameters with AUC larger than 0.5 was selected to establish the prediction model of CDAI. Totally seven ultrasound parameters (bowel wall thickness, mesenteric fat thickness, peristalsis, texture of enhancement, Limberg grade, bowel wall perforation and bowel wall stratification) were significantly different between active and inactive group. A regression model was established based on the seven parameters as followed: CDAI = 211.325 + 3.186BWT - 53.003BWS + 6.280BWP + 0.392MFT + 22.239PS + 79.012LG + 72.793TE. (R2 = 0.72, P = 0.037). The multimodal ultrasound parametric regression model was designed to predict CDAI score invasively. The model has the potential to provide an alternative method for quantifying the CD activity.
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
The value of multi-modes of ultrasound in evaluating segmental mucosal healing in patients with Crohn's disease.Dig Liver Dis. 2022 Jun;54(6):763-770. doi: 10.1016/j.dld.2021.12.009. Epub 2022 Jan 3. Dig Liver Dis. 2022. PMID: 34991975
-
Different imaging techniques' diagnostic efficacy for Crohn's disease activity and external validation and comparison of MDCTAs, SES-CD and IBUSSAS.BMC Gastroenterol. 2024 Aug 20;24(1):277. doi: 10.1186/s12876-024-03376-8. BMC Gastroenterol. 2024. PMID: 39164662 Free PMC article.
-
Longitudinal Bowel Behavior Assessed by Bowel Ultrasound to Predict Early Response to Anti-TNF Therapy in Patients With Crohn's Disease: A Pilot Study.Inflamm Bowel Dis. 2022 Jun 2;28(Suppl 2):S67-S75. doi: 10.1093/ibd/izab353. Inflamm Bowel Dis. 2022. PMID: 34984455
-
Ultrasound in Crohn's disease of the small bowel.Eur J Radiol. 2000 Sep;35(3):176-82. doi: 10.1016/s0720-048x(00)00240-0. Eur J Radiol. 2000. PMID: 11000560
-
Assessment of inflammatory and fibrotic stenoses in patients with Crohn's disease using contrast-enhanced ultrasound and computerized algorithm: a pilot study.Digestion. 2011;83(4):263-8. doi: 10.1159/000321389. Epub 2011 Jan 28. Digestion. 2011. PMID: 21273775
Cited by
-
Extracellular Matrix Components as Diagnostic Tools in Inflammatory Bowel Disease.Biology (Basel). 2021 Oct 11;10(10):1024. doi: 10.3390/biology10101024. Biology (Basel). 2021. PMID: 34681123 Free PMC article. Review.
-
Diagnostic accuracy of different cross-sectional imaging techniques for disease location and activity in Crohn's disease and external validation and comparison of MARIAs and IBUS-SAS.Abdom Radiol (NY). 2023 Mar;48(3):821-832. doi: 10.1007/s00261-022-03751-7. Epub 2022 Dec 16. Abdom Radiol (NY). 2023. PMID: 36525049
-
Current Developments and Role of Intestinal Ultrasound including the Advent of AI.Diagnostics (Basel). 2024 Apr 3;14(7):759. doi: 10.3390/diagnostics14070759. Diagnostics (Basel). 2024. PMID: 38611672 Free PMC article. Review.
-
Quantitative assessment of ultrasound microvessel imaging in Crohn's disease: correlation with pathological inflammation.Eur Radiol. 2025 May;35(5):2806-2817. doi: 10.1007/s00330-024-11156-x. Epub 2024 Nov 16. Eur Radiol. 2025. PMID: 39547980
-
Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn's disease treated with ustekinumab.Therap Adv Gastroenterol. 2024 Jun 22;17:17562848241259289. doi: 10.1177/17562848241259289. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38912296 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical